New target: Researchers identify pancreatic cancer resistance mechanism
Pancreatic cancer tumors addicted to mutant Kras signaling for their growth
and progression have a ready-made substitute to tap if they're ever forced to go
cold-turkey on the mutant oncogene, scientists at The University of Texas MD Anderson Cancer
Center report in the journal Cell.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news
More News: Addiction | Cancer | Cancer & Oncology | Middle East Health | Pancreas | Pancreatic Cancer | Texas University